Identification of Toxoplasma gondii cAMP dependent protein kinase and its role in the tachyzoite growth

PLoS One. 2011;6(7):e22492. doi: 10.1371/journal.pone.0022492. Epub 2011 Jul 20.

Abstract

Background: cAMP-dependent protein kinase (PKA) has been implicated in the asexual stage of the Toxoplasma gondii life cycle through assaying the effect of a PKA-specific inhibitor on its growth rate. Since inhibition of the host cell PKA cannot be ruled out, a more precise evaluation of the role of PKA, as well as characterization of the kinase itself, is necessary.

Methodology/principal finding: The inhibitory effects of two PKA inhibitors, H89, an ATP-competitive chemical inhibitor, and PKI, a substrate-competitive mammalian natural peptide inhibitor, were estimated. In the in vitro kinase assay, the inhibitory effect of PKI on a recombinant T. gondii PKA catalytic subunit (TgPKA-C) was weaker compared to that on mammalian PKA-C. In a tachyzoite growth assay, PKI had little effect on the growth of tachyzoites, whereas H89 strongly inhibited it. Moreover, T. gondii PKA regulatory subunit (TgPKA-R)-overexpressing tachyzoites showed a significant growth defect.

Conclusions/significance: Our data suggest that PKA plays an important role in the growth of tachyzoites, and the inhibitory effect of substrate-competitive inhibitor PKI on T. gondii PKA was low compared to that of the ATP competitive inhibitor H89.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Amino Acid Sequence
  • Binding, Competitive
  • Catalytic Domain
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic AMP-Dependent Protein Kinases / chemistry
  • Cyclic AMP-Dependent Protein Kinases / genetics
  • Cyclic AMP-Dependent Protein Kinases / metabolism*
  • Gene Expression Regulation, Enzymologic
  • Isoquinolines / pharmacology
  • Molecular Sequence Data
  • Peptides / pharmacology
  • Protein Kinase Inhibitors / pharmacology
  • Sulfonamides / pharmacology
  • Toxoplasma / enzymology*
  • Toxoplasma / growth & development*

Substances

  • Isoquinolines
  • Peptides
  • Protein Kinase Inhibitors
  • Sulfonamides
  • protein kinase inhibitor peptide
  • Adenosine Triphosphate
  • Cyclic AMP-Dependent Protein Kinases
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide